Based on the assigning task on Cash flows of 5 companies that follow or not follow IAS 7

standard, I have studied 5 companies annual reports along with financial reports. I found some of
them are following IAS 7 standard to made their financial report and some companies are not
following. My findings are here below one after another.

Statement of cash flows presents inflows and outflows of cash and cash equivalents and is dealt
with in IAS 7. The statement of cash flows is required to be presented by all entities for each
period for which financial statements are presented.

Beximco Pharmaceutical limited: Beximco Pharmaceuticals Ltd (Beximco Pharma) is a

leading manufacturer and exporter of medicines in Bangladesh. Incorporated in the late 70s,
Beximco Pharma began as a distributor, importing products from global MNCs like Bayer,
Germany and Upjohn, USA and selling them in the local market, which were later manufactured
and distributed under licensing arrangement. Since then, the journey continued, and today,
Beximco Pharma is one of the largest exporters of medicines in Bangladesh, winning National
Export Trophy (Gold) a record five times.

The financial statements of Beximco Pharmaceutical Limited prepared in accordance with

International Financial Reporting Standards (IFRSs), including International Accounting
Standards (IASs), give a true and fair view of the state of the company's affairs as of December
31, 2008 and of the results of its operations and its cash flows for the year then ended and
comply with the applicable sections of IAS 7 all steps like,

in the Operating activities, beximco followed both direct and on direct methods and to do so
they have clearly mentioned

• the cash receipts from the sales of goods and the rendering of services.

• The cash receipts from royalties, fees, commissions and others revenue.

• Cash payments to suppliers for goods and services.

• Cash payments to and on behalf of employees.

 • Cash receipts and cash payments of an insurance entity for premiums and claim, annuities
other policy benefits.

• Cash payments and refunds of income taxes unless they can be specifically identified
with financial and investing activities etc

in the Investing activities they have clearly mentioned

• About the cash payment to acquire property, plant, and equipment, intangible and other
long term assets.

• cash receipts from sales of property, plant and equipment, intangibles and other long term
assets

• cash payments to acquire equity or debt instruments of other entities and interests in joint
ventures

• cash receipts from sales of equity or debt instruments of other entities and interests in
joint ventures

• cash receipts from the repayment of advances and loans made to other parties (other than
advances and loans of a financial institution

• cash payments and received for futures contracts, forward contracts, option contracts and
swap contracts except when the contracts are held for dealing or trading purposes, or the
payments are classified as financing activities.
in the Financial activities they have clearly mentioned

• cash proceeds from issuing shares or other equity instruments

• cash payments to owners to acquire or redeem the entity’s shares

• cash proceeds from issuing debentures, loans, notes, bonds, mortgages and other short-
term or long-term borrowings

• cash repayments of amounts borrowed etc.

Renata limited (formerly Pfizer limited) is one of the main and quickest-developing
pharmaceutical and animal health product agencies in Bangladesh. The enterprise commenced its
operations in 1972 as Pfizer (Bangladesh) limited. In 1993, Pfizer transferred the ownership of
its Bangladesh operations to local shareholders and the name of the agency was changed to
Renata limited.

The financial statements of Renata limited prepared in accordance with International Financial
Reporting Standards (IFRSs), including International Accounting Standards (IASs), give a true
and fair view of the state of the company's affairs as of December 31, 2008 and of the results of
its operations and its cash flows for the year then ended and comply with the applicable sections
of IAS 7 all steps like,

in the Operating activities, Renata followed both direct and on direct methods and to do so they
have clearly mentioned

• the cash receipts from the sales of goods and the rendering of services.

• The cash receipts from royalties, fees, commissions and others revenue.

• Cash payments to suppliers for goods and services.

• Cash payments to and on behalf of employees.

• Cash receipts and cash payments of an insurance entity for premiums and claim, annuities
other policy benefits.
 • Cash payments and refunds of income taxes unless they can be specifically identified
with financial and investing activities etc.

in the Investing activities they have clearly mentioned

• About the cash payment to acquire property, plant, and equipment, intangible and other
long-term assets.

• cash receipts from sales of property, plant and equipment, intangibles and other long term
assets

• cash payments to acquire equity or debt instruments of other entities and interests in joint
ventures

• cash receipts from sales of equity or debt instruments of other entities and interests in
joint ventures

• cash receipts from the repayment of advances and loans made to other parties (other than
advances and loans of a financial institution

• cash payments and received for futures contracts, forward contracts, option contracts and
swap contracts except when the contracts are held for dealing or trading purposes, or the
payments are classified as financing activities.

in the Financial activities they have clearly mentioned

• cash proceeds from issuing shares or other equity instruments

• cash payments to owners to acquire or redeem the entity’s shares

• cash proceeds from issuing debentures, loans, notes, bonds, mortgages and other short-
term or long-term borrowings

• cash repayments of amounts borrowed etc.

ACI's task is to attain commercial enterprise excellence via quality by using knowledge,
accepting, meeting, and exceeding client expectations. ACI follows the international standards
on best control system to make certain the consistent pleasant of services and products to obtain
patron pleasure. ACI additionally meets all national regulatory necessities relating to its cutting-
edge businesses and ensures that cutting-edge excellent production Practices (cGMP) as
endorsed by means of the arena fitness organization are accompanied well. ACI has been typical
as a Founding Member of the community of global boom corporations by using the world
financial discussion board that is the most prestigious enterprise networking business enterprise.

ACI was set up as the subsidiary of Imperial Chemical Industries (ICI) inside the then East
Pakistan in 1968. After independence, the agency has been integrated in Bangladesh at the 24th
of January 1973 as ICI Bangladesh manufacturers limited and additionally as a Public limited
company.

The financial statements of ACI prepared in accordance with International Financial Reporting
Standards (IFRSs), including International Accounting Standards (IASs), give a true and fair
view of the state of the company's affairs as of December 31, 2008 and of the results of its
operations and its cash flows for the year then ended and comply with the applicable sections of
IAS 7 all steps like,

in the Operating activities, ACI followed both direct and on direct methods and to do so they
have clearly mentioned

• the cash receipts from the sales of goods and the rendering of services.

• The cash receipts from royalties, fees, commissions and others revenue.

• Cash payments to suppliers for goods and services.

• Cash payments to and on behalf of employees.

 • Cash receipts and cash payments of an insurance entity for premiums and claim, annuities
other policy benefits.

• Cash payments and refunds of income taxes unless they can be specifically identified
with financial and investing activities etc.

in the Investing activities they have clearly mentioned

• About the cash payment to acquire property, plant, and equipment, intangible and other
long-term assets.

• cash receipts from sales of property, plant and equipment, intangibles and other long term
assets

• cash payments to acquire equity or debt instruments of other entities and interests in joint
ventures

• cash receipts from sales of equity or debt instruments of other entities and interests in
joint ventures

• cash receipts from the repayment of advances and loans made to other parties (other than
advances and loans of a financial institution

• cash payments and received for futures contracts, forward contracts, option contracts and
swap contracts except when the contracts are held for dealing or trading purposes, or the
payments are classified as financing activities.

in the Financial activities they have clearly mentioned

• cash proceeds from issuing shares or other equity instruments

• cash payments to owners to acquire or redeem the entity’s shares

• cash proceeds from issuing debentures, loans, notes, bonds, mortgages and other short-
term or long-term borrowings

• cash repayments of amounts borrowed etc.

Delta Pharma Ltd business enterprise in Bangladesh which focused on improving patients lives
by figuring out, growing, and producing significant products that reflect Their motto: higher
Care higher Cure As a part of our commitment to our sufferers, we're continuing to increase our
product portfolio and research and improvement which could have an impact on Their same
understanding. They continually stay committed to the highest standards of quality, protection,
and integrity. Their willpower is based totally on respect for the individual, as well as the groups
and the world in which we live. Our venture is to advantage the us humans and improve their
fine of lifestyles with our excellent services. They would like to ensure consumer pleasure by
means of offering quality offerings at an low cost.

The financial statements of Delta Pharma Ltd prepared in accordance with International
Financial Reporting Standards (IFRSs), including International Accounting Standards (IASs),
give a true and fair view of the state of the company's affairs as of December 31, 2008 and of the
results of its operations and its cash flows for the year then ended and comply with the applicable
sections of IAS 7 all steps like,

in the Operating activities, Delta Pharma Ltd followed both direct and on direct methods and to
do so they have clearly mentioned

• the cash receipts from the sales of goods and the rendering of services.

• The cash receipts from royalties, fees, commissions and others revenue.

• Cash payments to suppliers for goods and services.

• Cash payments to and on behalf of employees.

• Cash receipts and cash payments of an insurance entity for premiums and claim, annuities
other policy benefits.
 • Cash payments and refunds of income taxes unless they can be specifically identified
with financial and investing activities etc.

in the Investing activities they have clearly mentioned

• About the cash payment to acquire property, plant, and equipment, intangible and other
long-term assets.

• cash receipts from sales of property, plant and equipment, intangibles and other long term
assets

• cash payments to acquire equity or debt instruments of other entities and interests in joint
ventures

• cash receipts from sales of equity or debt instruments of other entities and interests in
joint ventures

• cash receipts from the repayment of advances and loans made to other parties (other than
advances and loans of a financial institution

• cash payments and received for futures contracts, forward contracts, option contracts and
swap contracts except when the contracts are held for dealing or trading purposes, or the
payments are classified as financing activities.

in the Financial activities they have clearly mentioned

• cash proceeds from issuing shares or other equity instruments

• cash payments to owners to acquire or redeem the entity’s shares

• cash proceeds from issuing debentures, loans, notes, bonds, mortgages and other short-
term or long-term borrowings

• cash repayments of amounts borrowed etc.

Drug international limited became included beneath the Registrar of Joint stock groups in 1974
as a non-public limited organization. The enterprise commenced formulation and production in
1983 and emerged as a pioneer in Bangladesh for adding a state of the art oral stable dosage
plant. since its inception, Drug international Limited’s number one objective has been to meet
guidelines supplied by using primary international regulatory bodies inclusive of the world
health organization properly manufacturing Practices (WHO cGMP) pointers.

The financial statements of Drug international limited prepared in accordance with International
Financial Reporting Standards (IFRSs), including International Accounting Standards (IASs),
give a true and fair view of the state of the company's affairs as of December 31, 2008 and of the
results of its operations and its cash flows for the year then ended and comply with the applicable
sections of IAS 7 all steps like,

in the Operating activities, Drug international limited followed both direct and on direct
methods and to do so they have clearly mentioned

• the cash receipts from the sales of goods and the rendering of services.

• The cash receipts from royalties, fees, commissions and others revenue.

• Cash payments to suppliers for goods and services.

• Cash payments to and on behalf of employees.

• Cash receipts and cash payments of an insurance entity for premiums and claim, annuities
other policy benefits.

• Cash payments and refunds of income taxes unless they can be specifically identified
with financial and investing activities etc

in the Investing activities they have clearly mentioned

 • About the cash payment to acquire property, plant, and equipment, intangible and other
long-term assets.

• cash receipts from sales of property, plant and equipment, intangibles and other long term
assets

• cash payments to acquire equity or debt instruments of other entities and interests in joint
ventures

• cash receipts from sales of equity or debt instruments of other entities and interests in
joint ventures

• cash receipts from the repayment of advances and loans made to other parties (other than
advances and loans of a financial institution

• cash payments and received for futures contracts, forward contracts, option contracts and
swap contracts except when the contracts are held for dealing or trading purposes, or the
payments are classified as financing activities.

in the Financial activities they have clearly mentioned

• cash proceeds from issuing shares or other equity instruments

• cash payments to owners to acquire or redeem the entity’s shares

• cash proceeds from issuing debentures, loans, notes, bonds, mortgages and other short-
term or long-term borrowings

• cash repayments of amounts borrowed etc.